Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription 17.05.2021 1 Am J Surg 15 Ann Surg Oncol 3 Anticancer Res 10 BMC Cancer 11 BMC Gastroenterol 2 Br J Cancer 2 Br J Surg 1 Cancer 1 Cancer Res 1 Dig Dis 2 Gastroenterology 1 Gastrointest Endosc 1 Gut 1 Int J Cancer 3 Int J Colorectal Dis 2 Oncogene 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. GOLDNER M, Platoff R, Betances A, De Leo N, et al
   Role of metastasectomy for liver metastasis in stage IV anal cancer.
   Am J Surg. 2021;221:832-838.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. CHAO YK
   Is It Time to Add Tumor Regression Grade into the ypN Category?
   Ann Surg Oncol. 2021;28:1880-1881.
   PubMed        
   
   
3. HUISMAN JF, Schoenaker IJH, Brohet RM, Reerink O, et al
   Avoiding Unnecessary Major Rectal Cancer Surgery by Implementing Structural Restaging and a Watch-and-Wait Strategy After Neoadjuvant Radiochemotherapy.
   Ann Surg Oncol. 2021;28:2811-2818.
   PubMed         Abstract available
   
   
4. D'ALIMONTE L, Bao QR, Spolverato G, Capelli G, et al
   Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
   Ann Surg Oncol. 2021;28:2801-2808.
   PubMed         Abstract available
   
   
5. SPENCE RT, Hirpara DH, Doshi S, Quereshy FA, et al
   Will My Patient Survive an Anastomotic Leak? Predicting Failure to Rescue Using the Modified Frailty Index.
   Ann Surg Oncol. 2021;28:2779-2787.
   PubMed         Abstract available
   
   
6. BAO QR, Capelli G, Spolverato G, Pucciarelli S, et al
   ASO Author Reflections: Local Excision Following Neoadjuvant Therapy for Rectal Cancer: A Compromise Between TME and Watch-and-Wait in Patients with Major Response.
   Ann Surg Oncol. 2021;28:2809-2810.
   PubMed        
   
   
7. GAMBOA AC, Lee RM, Turgeon MK, Varlamos C, et al
   Impact of Postoperative Complications on Oncologic Outcomes After Rectal Cancer Surgery: An Analysis of the US Rectal Cancer Consortium.
   Ann Surg Oncol. 2021;28:1712-1721.
   PubMed         Abstract available
   
   
8. DOKMAK S, Aussilhou B, Levenson G, Guarneri G, et al
   Staged Double Hepatectomy, Double Total Vascular Exclusion, and Double Venous Reconstruction by Peritoneal Patches in One Patient with Colorectal Liver Metastases.
   Ann Surg Oncol. 2021;28:2028-2029.
   PubMed         Abstract available
   
   
9. TRUANT S, Baillet C, Gnemmi V, Fulbert M, et al
   The Impact of Modern Chemotherapy and Chemotherapy-Associated Liver Injuries (CALI) on Liver Function: Value of 99mTc-Labelled-Mebrofenin SPECT-Hepatobiliary Scintigraphy.
   Ann Surg Oncol. 2021;28:1959-1969.
   PubMed         Abstract available
   
   
10. DE BELLIS M, Vega EA, Kawaguchi Y, Panettieri E, et al
    Simultaneous Sigmoid Colectomy, Bilobar Liver Resection and Lung Metastasectomy via a Transdiaphragmatic Approach for Stage IV Colonic Adenocarcinoma.
    Ann Surg Oncol. 2021;28:863-864.
    PubMed         Abstract available
    
    
11. SAADAT LV, Boerner T, Goldman DA, Gonen M, et al
    Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2021;28:817-825.
    PubMed         Abstract available
    
    
12. BUISMAN FE, Filipe WF, Kemeny NE, Narayan RR, et al
    Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.
    Ann Surg Oncol. 2021;28:808-816.
    PubMed         Abstract available
    
    
13. LURVINK RJ, Tajzai R, Rovers KP, Wassenaar ECE, et al
    Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial.
    Ann Surg Oncol. 2021;28:265-272.
    PubMed         Abstract available
    
    
14. DIXON MEB, Gusani NJ
    Bilobar Colorectal Liver Metastases: Challenges and Opportunities.
    Ann Surg Oncol. 2021;28:1268-1270.
    PubMed        
    
    
15. BIJELIC L, Ramos I, Goere D
    The Landmark Series: Surgical Treatment of Colorectal Cancer Peritoneal Metastases.
    Ann Surg Oncol. 2021 May 9. pii: 10.1245/s10434-021-10049.
    PubMed         Abstract available
    
    
16. ROSSI AJ, Khan TM, Hong H, Lesinski GB, et al
    Pepinemab (Anti-SEMA4D) in Combination with Ipilimumab or Nivolumab for Patients with Resectable Pancreatic and Colorectal Cancer.
    Ann Surg Oncol. 2021 May 13. pii: 10.1245/s10434-021-10111.
    PubMed        
    
    

    
    Anticancer Res

17. NUMATA M, Tamagawa H, Kazama K, Atsumi Y, et al
    Potential Benefits of Minimally Invasive Laparoscopy in Reducing Local Recurrence After Surgery for Low Rectal Cancer.
    Anticancer Res. 2021;41:2617-2623.
    PubMed         Abstract available
    
    
18. ELLIOT AH, Othman BN, Suzuki C, Blomqvist L, et al
    Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence.
    Anticancer Res. 2021;41:2459-2465.
    PubMed         Abstract available
    
    
19. SHIBUTANI M, Kimura K, Kashiwagi S, Wang EN, et al
    Elevated Postoperative Levels of Serum C-reactive Protein Are Associated With Shorter Long-term Survival After Resection of Colorectal Liver Metastases, Regardless of the Occurrence of Infectious Complications.
    Anticancer Res. 2021;41:2605-2610.
    PubMed         Abstract available
    
    

    
    BMC Cancer

20. PAKU M, Uemura M, Kitakaze M, Fujino S, et al
    Impact of the preoperative prognostic nutritional index as a predictor for postoperative complications after resection of locally recurrent rectal cancer.
    BMC Cancer. 2021;21:435.
    PubMed         Abstract available
    
    
21. SAKAI N, Furukawa K, Takayashiki T, Kuboki S, et al
    Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases.
    BMC Cancer. 2021;21:412.
    PubMed         Abstract available
    
    
22. ZOK J, Bienkowski M, Radecka B, Korniluk J, et al
    Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study.
    BMC Cancer. 2021;21:529.
    PubMed         Abstract available
    
    
23. ZHANG M, Yang J, Jiang H, Jiang H, et al
    Correlation between glucose metabolism parameters derived from FDG and tumor TNM stages and metastasis-associated proteins in colorectal carcinoma patients.
    BMC Cancer. 2021;21:258.
    PubMed         Abstract available
    
    
24. ARAUJO LH, Souza BM, Leite LR, Parma SAF, et al
    Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer.
    BMC Cancer. 2021;21:193.
    PubMed         Abstract available
    
    
25. IWAYA M, Ota H, Nakajima T, Uehara T, et al
    Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
    BMC Cancer. 2021;21:119.
    PubMed         Abstract available
    
    
26. MIWA K, Oki E, Enomoto M, Ihara K, et al
    Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301).
    BMC Cancer. 2021;21:23.
    PubMed         Abstract available
    
    
27. YANG S, Bian J, George TJ, Daily K, et al
    The association between cognitive impairment and breast and colorectal cancer screening utilization.
    BMC Cancer. 2021;21:539.
    PubMed         Abstract available
    
    
28. VANIA L, Morris G, Ferreira E, Weiss SFT, et al
    Knock-down of LRP/LR influences signalling pathways in late-stage colorectal carcinoma cells.
    BMC Cancer. 2021;21:392.
    PubMed         Abstract available
    
    
29. BESUTTI G, Damato A, Venturelli F, Bonelli C, et al
    Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients.
    BMC Cancer. 2021;21:253.
    PubMed         Abstract available
    
    

    
    BMC Gastroenterol

30. QIN X, Liu CY, Xiong YL, Bai T, et al
    The clinical features of chronic intestinal schistosomiasis-related intestinal lesions.
    BMC Gastroenterol. 2021;21:12.
    PubMed         Abstract available
    
    
31. XIE TH, Su P, Hong JG, Zhang H, et al
    Cervical lymph node enlargement as the initial manifestation of rectal cancer.
    BMC Gastroenterol. 2021;21:57.
    PubMed         Abstract available
    
    
32. YKEMA BLM, Bisseling TM, Spaander MCW, Moons LMG, et al
    Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study.
    BMC Gastroenterol. 2021;21:67.
    PubMed         Abstract available
    
    
33. NORTHCUTT MJ, Shi Z, Zijlstra M, Shah A, et al
    Polygenic risk score is a predictor of adenomatous polyps at screening colonoscopy.
    BMC Gastroenterol. 2021;21:65.
    PubMed         Abstract available
    
    
34. TACHIKAWA J, Chiba H, Okada N, Arimoto J, et al
    Impact of obesity in colorectal endoscopic submucosal dissection: single-center retrospective cohort study.
    BMC Gastroenterol. 2021;21:74.
    PubMed         Abstract available
    
    
35. KUERBANJIANG A, Maimaituerxun M, Zhang Y, Li Y, et al
    V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) as a prognostic biomarker of poor outcomes in esophageal cancer patients.
    BMC Gastroenterol. 2021;21:86.
    PubMed         Abstract available
    
    
36. LEE KY, Lee J, Park YY, Oh ST, et al
    Routine colonoscopy may be needed for uncomplicated acute right colonic diverticulitis.
    BMC Gastroenterol. 2021;21:91.
    PubMed         Abstract available
    
    
37. OKAMOTO Y, Oka S, Tanaka S, Kamigaichi Y, et al
    Effect of educational lecture on the diagnostic accuracy of Japan NBI Expert Team classification for colorectal lesions.
    BMC Gastroenterol. 2021;21:110.
    PubMed         Abstract available
    
    
38. KUROKI H, Sugita A, Koganei K, Tatsumi K, et al
    Clinicopathological and prognostic evaluations of anorectal cancer after fecal diversion for patients with Crohn's disease.
    BMC Gastroenterol. 2021;21:168.
    PubMed         Abstract available
    
    
39. WANG XY, Chai NL, Zhai YQ, Li LS, et al
    Hybrid endoscopic submucosal dissection: An alternative resection modality for large laterally spreading tumors in the cecum?
    BMC Gastroenterol. 2021;21:203.
    PubMed         Abstract available
    
    
40. SHAN K, Lu H, Zhang Z, Xie J, et al
    Impact of second forward-view examination on adenoma detection rate during unsedated colonoscopy: a randomized controlled trial.
    BMC Gastroenterol. 2021;21:213.
    PubMed         Abstract available
    
    

    
    Br J Cancer

41. OUAHOUD S, Jacobs RJ, Peppelenbosch MP, Fuhler GM, et al
    Correction: Kinome-wide analysis of the effect of statins in colorectal cancer.
    Br J Cancer. 2021 May 10. pii: 10.1038/s41416-021-01426.
    PubMed        
    
    
42. KREGTING LM, Kaljouw S, de Jonge L, Jansen EEL, et al
    Effects of cancer screening restart strategies after COVID-19 disruption.
    Br J Cancer. 2021;124:1516-1523.
    PubMed         Abstract available
    
    

    
    Br J Surg

43. DE HINGH IHJT
    Heated intraperitoneal chemotherapy for colorectal cancer: game over or game on?
    Br J Surg. 2021 May 10. pii: 6273040. doi: 10.1093.
    PubMed        
    
    
44. DONG DZ, Dong QS, Zhang FN, Li CL, et al
    Impact of COVID-19 on treatment modalities and short-term outcomes of rectal cancer following neoadjuvant chemoradiotherapy: a retrospective study.
    Br J Surg. 2021;108:e164-e165.
    PubMed        
    
    

    
    Cancer

45. CHUDY-ONWUGAJE K, Huang WY, Su LJ, Purdue MP, et al
    Aspirin, ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO Cancer Screening Trial.
    Cancer. 2021 May 11. doi: 10.1002/cncr.33623.
    PubMed         Abstract available
    
    

    
    Cancer Res

46. SHEN M, Xie S, Rowicki M, Michel S, et al
    Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis.
    Cancer Res. 2020 Nov 25. pii: 0008-5472.CAN-20-1876.
    PubMed         Abstract available
    
    

    
    Dig Dis

47. TEPES B, Stefanovic M, Stabuc B, Novak Mlakar D, et al
    Quality Control in the Slovenian National Colorectal Cancer Screening Program.
    Dig Dis. 2021 May 9. pii: 000516978. doi: 10.1159/000516978.
    PubMed        
    
    

    
    Gastroenterology

48. DUBE C
    Re-FIT-ting colorectal cancer screening during and beyond COVID.
    Gastroenterology. 2021 May 8. pii: S0016-5085(21)00752.
    PubMed        
    
    
49. MORI Y, Bretthauer M, Kalager M
    Hopes and hypes for artificial intelligence in colorectal cancer screening.
    Gastroenterology. 2021 May 11. pii: S0016-5085(21)02973.
    PubMed        
    
    

    
    Gastrointest Endosc

50. LIEBERMAN D
    Challenges for colorectal cancer screening decision modeling.
    Gastrointest Endosc. 2021 May 8. pii: S0016-5107(21)00300.
    PubMed        
    
    

    
    Gut

51. CURTIUS K, Kabir M, Al Bakir I, Choi CHR, et al
    Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool.
    Gut. 2021 May 14. pii: gutjnl-2020-323546. doi: 10.1136/gutjnl-2020-323546.
    PubMed         Abstract available
    
    

    
    Int J Cancer

52. ZORZI M, Battagello J, Fiore A, Memo L, et al
    Colorectal cancer incidence and mortality after negative fecal immunochemical tests by age 70: a prospective observational study.
    Int J Cancer. 2021 May 14. doi: 10.1002/ijc.33682.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

53. DOMPER ARNAL MJ, Garcia Mateo S, Hermoso-Duran S, Abad D, et al
    False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use.
    Int J Colorectal Dis. 2021 May 12. pii: 10.1007/s00384-021-03947.
    PubMed         Abstract available
    
    
54. DEGETT TH, Christensen J, Dalton SO, Bossen K, et al
    Prediction of the postoperative 90-day mortality after acute colorectal cancer surgery: development and temporal validation of the ACORCA model.
    Int J Colorectal Dis. 2021 May 12. pii: 10.1007/s00384-021-03950.
    PubMed         Abstract available
    
    
55. FERRI V, Vicente E, Quijano Y, Duran H, et al
    Right-side colectomy with complete mesocolic excision vs conventional right-side colectomy in the treatment of colon cancer: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2021 May 13. pii: 10.1007/s00384-021-03951.
    PubMed         Abstract available
    
    

    
    Oncogene

56. ZHANG XL, Hu LP, Yang Q, Qin WT, et al
    CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-beta receptors in colorectal cancer.
    Oncogene. 2021 May 13. pii: 10.1038/s41388-021-01827.
    PubMed         Abstract available
    
    
57. CHEN J, Na R, Xiao C, Wang X, et al
    The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy.
    Oncogene. 2021 May 14. pii: 10.1038/s41388-021-01815.
    PubMed         Abstract available
    
    

    
    PLoS One

58. ALHARBI A, Bin Dokhi H, Almuhaini G, Alomran F, et al
    Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia.
    PLoS One. 2021;16:e0249590.
    PubMed         Abstract available
    
    
59. HONDA M, Naoe H, Gushima R, Miyamoto H, et al
    Risk stratification for advanced colorectal neoplasia based on the findings of the index and first surveillance colonoscopies.
    PLoS One. 2021;16:e0245211.
    PubMed         Abstract available
    
    
60. GUO Y, Guo Y, Luo Y, Song X, et al
    Comparison of pathologic outcomes of robotic and open resections for rectal cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245154.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: